SpyGlass Pharma, Inc. Common Stock beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.48 | $-0.59 | -22.9% | Miss |
| Q12026 FY2026 | $-0.67 | $-0.69 | -3.0% | Miss |
| Q42025 FY2025 | $-6.61 | $-5.72 | +13.5% | Beat |
Back to SGP overview · SGP holders · SGP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.